GWMR
VERA icon

GC Wealth Management RIA’s Vera Therapeutics VERA Stock Holding History

GC Wealth Management RIA’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$573K Sell
13,353
-10,646
-44% -$397K 0.03% 310
2026
Q1 		$965K Buy
23,999
+14
+0.1% +$603 0.04% 243
2025
Q4 		$1.21M Sell
23,985
-14,900
-38% -$529K 0.04% 214
2025
Q3 		$1.13M Buy
38,885
+25,318
+187% +$585K 0.04% 296
2025
Q2 		$320K Buy
+13,567
New +$305K 0.03% 423

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

GC Wealth Management RIA's VERA Position: Q2 2026 in Review

GC Wealth Management RIA reduced its Vera Therapeutics (VERA) stake by 44% in Q2 2026, selling an estimated $397K and leaving 13,353 shares worth $573K. The position accounts for 0.03% of the portfolio, ranked #310.

GC Wealth Management RIA first reported a position in VERA in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.21M in Q4 2025. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • GC Wealth Management RIA held 13,353 shares of Vera Therapeutics worth $573K as of Q2 2026.
  • GC Wealth Management RIA sold 10,646 Vera Therapeutics shares in Q2 2026, an estimated $397K.
  • Vera Therapeutics made up 0.03% of GC Wealth Management RIA's portfolio in Q2 2026, its #310 holding.
  • GC Wealth Management RIA first reported a position in Vera Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • GC Wealth Management RIA's Vera Therapeutics position peaked at $1.21M in Q4 2025.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on GC Wealth Management RIA's 13F filing for Q2 2026, filed 16 Jul 2026.